ArticleMolecular cancer therapeutics2026

NOUS-209 Off-the-shelf Immunotherapy Has the Potential to Hit Primary and Metachronous Colorectal and Urothelial Cancers in Lynch Syndrome.

Lorenzo De Marco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.